NOVELION THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 26 Jul 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87043469
- Registration number
- 5381456
- Mark type
- Stylized text
- Filed
- 19 May 2016
- Published for opposition
- 25 Apr 2017
- Registered
- 16 Jan 2018
- Attorney of record
- Todd Armstrong
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- NOVELION THERAPEUTICS, INC., CAMBRIDGE, MA, CA
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 26 Jul 2024 — CANCELLED SEC. 8 (6-YR)
- 16 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Sept 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Apr 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Nov 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Nov 2017 — USE AMENDMENT FILED
- 21 Nov 2017 — SOU EXTENSION 1 GRANTED
- 14 Nov 2017 — SOU EXTENSION 1 FILED
- 20 Nov 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Nov 2017 — SOU TEAS EXTENSION RECEIVED
- 14 Nov 2017 — TEAS STATEMENT OF USE RECEIVED